Bronzing Duo SPF 15 Mineral Compact Tint 02 Medium
Dosage form: powder
Ingredients: TITANIUM DIOXIDE 8.4g in 100g
Labeler: Laboratoires Clarins S.A.
NDC Code: 58668-5361
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
TITANIUM DIOXIDE : 8.4%
TALC . ZINC STEARATE . ZEA MAYS (CORN) STARCH . OCTYLDODECYL STEAROYL STEARATE . DIMETHICONE . DIISOSTEARYL MALATE . PENTAERYTHRITYL TETRAISOSTEARATE . GLYCERIN . EMPETRUM NIGRUM FRUIT JUICE . SILICA . NYLON-12 . ASCORBYL PALMITATE . PARFUM/FRAGRANCE . TOCOPHEROL . HDI/TRIMETHYLOL HEXYLLACTONE CROSSPOLYMER . AQUA/ WATER . BUTYLENE GLYCOL . RETINYL PALMITATE . BENZYL SALICYLATE . HYDROXYETHYL UREA . LIMONENE . CAMELLIA SINENSIS LEAF EXTRACT . BUTYLPHENYL METHYLPROPIONAL . PHENOXYETHANOL . POTASSIUM SORBATE . ALGIN . ACACIA SENEGAL GUM. ± /MAY CONTAIN/PEUT CONTENIR : [CI 77891/TITANIUM DIOXIDE . CI 77491/CI 77492/CI 77499/ IRON OXIDES . CI 77019/MICA . TIN OXIDE . ALUMINA . CI 19140/ YELLOW 5 LAKE]. [M2411A]
apply liberally. Reapply as needed.
for external use only, not to be swallowed. Avoid contact with eyes.
if signs of irritation or rash appear.
Sunscreen
This lightweight Bronzing Duo compact has two complementary shades that blend together for a natural-looking, sun-kissed complexion. Formulated with mineral and plant extracts that help protect and care for your skin. SPF 15. Dermatologist tested.
02 medium Bronzing Duo CLARINS PARIS SPF 15 Mineral Powder Compact 100%Mineral Screen e 10g 0.35 Oz. Net Wt. MFD FOR CLARINS PARIS 92200 Neuilly 95300 Pontoise - France Made in Italy Distrib. Canada: CLARINS CANADA Inc. 815 Desserte est Autoroute Chomedey ALVAL (QUEBEC) H7W 5N4 www.clarins.com
| BRONZING DUO SPF 15 MINERAL COMPACT TINT 02 MEDIUM
titanium dioxide powder |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Labeler - Laboratoires Clarins S.A. (503972197) |
| Establishment | |||
| Name | Address | ID/FEI | Operations |
| Laboratoires Clarins S.A. | 503972197 | manufacture | |
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
